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Abstract
Fast and accurate synaptic transmission requires high-density accumulation of neurotrans-
mitter receptors in the postsynaptic membrane. During development of the neuromuscular
junction, clustering of acetylcholine receptors (AChR) is one of the first signs of postsynaptic
specialization and is induced by nerve-released agrin. Recent studies have revealed that differ-
ent mechanisms regulate assembly vs stabilization of AChR clusters and of the postsynaptic
apparatus. MuSK, a receptor tyrosine kinase and component of the agrin receptor, and rapsyn,
an AChR-associated anchoring protein, play crucial roles in the postsynaptic assembly. Once
formed, AChR clusters and the postsynaptic membrane are stabilized by components of the dys-
trophin/utrophin glycoprotein complex, some of which also direct aspects of synaptic matura-
tion such as formation of postjunctional folds. Nicotinic receptors are also expressed across the
peripheral and central nervous system (PNS/CNS). These receptors are localized not only at the
pre- but also at the postsynaptic sites where they carry out major synaptic transmission. In neu-
rons, they are found as clusters at synaptic or extrasynaptic sites, suggesting that different
mechanisms might underlie this specific localization of nicotinic receptors. This review summa-
rizes the current knowledge about formation and stabilization of the postsynaptic apparatus at
the neuromuscular junction and extends this to explore the synaptic structures of interneuronal
cholinergic synapses.
Index Entries: Clustering; neuromuscular junction; cholinergic; synapse; synaptogenesis; agrin;
nicotinic receptors; postsynaptic density.
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Introduction
Synapses are the points of contact between
neurons and their target cells, and mediate cel-
lular communication in the nervous system. At
chemical synapses, neurotransmitter mole-
cules are released from synaptic vesicles in the
presynaptic nerve terminal and activate their
receptors in the opposing postsynaptic mem-
brane. To ensure rapid and reliable synaptic
transmission, these receptors must be present
at a high density in clusters located precisely
opposite sites of neurotransmitter release in
the nerve ending. Accordingly, clustering of
neurotransmitter receptors is a key aspect of
synaptogenesis and occurs early during the
formation of both central and peripheral
synapses (1).
Much of the current knowledge about clus-
tering of neurotransmitter receptors originates
from studies on the vertebrate neuromuscular
junction (NMJ). At this peripheral cholinergic
synapse, many identified proteins interact to
form a postsynaptic apparatus in the muscle,
whose hallmark is the accumulation of nico-
tinic acetylcholine receptors (AChRs) in high
density, reaching up to 10,000 molecules/µm2
(1; Fig. 1). Neuronal equivalents of this postsy-
naptic apparatus can be found in synapses in
the central nervous system (CNS). One of the
best-characterized examples are glutamatergic
synapses, where the postsynaptic density con-
tains a plethora of postsynaptic proteins
besides glutamate receptors (2).
Several extended reviews about the NMJ
have recently appeared (1,3–5), dealing with
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Fig. 1. The postsynaptic apparatus at the neuromuscular junction. Postsynaptic proteins and their interactions
are illustrated. For simplicity, not all isoforms of synaptically located proteins are shown. Similarly, segregation
of isoforms between the crests and troughs of postjunctional folds is neglected. p, tyrosine phosphorylation.
all aspects of NMJ formation, maturation, and
elimination. Here, we focus largely on one key
aspect of synaptogenesis at the NMJ, the clus-
tering of AChRs, and show possible parallels
to localization of neuronal nicotinic receptors
at interneuronal cholinergic synapses. Recent
studies suggest that different proteins direct
formation vs maintenance of AChR clusters
and the postsynaptic apparatus at the NMJ.
Therefore, we divide the description of muscle
AChR clustering into two main parts, forma-
tion vs stabilization.
The Neuromuscular Junction:
Formation of AChR Clusters 
and the Postsynaptic Apparatus
The high density of postsynaptic AChRs at
the adult NMJ is accompanied by a 1000-fold
lower level of extrasynaptic AChRs and is the
result of three major signaling processes (1).
During development, before motorneurons
approach muscles, AChRs are diffusely distrib-
uted at a density of about 1000 receptors/µm2
throughout muscle fibers. First, upon contact
with the nerve ending, these pre-existing
AChRs are redistributed to form clusters at
sites of nerve-muscle contact. Second, muscle
nuclei underneath the nerve terminal start to
transcribe genes encoding AChRs at elevated
levels. Third, extrasynaptic nuclei cease the
transcription of AChR genes. Together, these
three processes cause the high density of
AChRs in the postsynaptic membrane and the
virtual absence of AChRs throughout the
extrasynaptic plasmalemma. In this review,
we largely focus on the first of these pro-
cesses, the clustering of AChRs.
Agrin and Neuregulin Are Two Key Factors
for Formation of the NMJ
During development of the NMJ, AChR
clustering is induced by agrin, a key proteogly-
can released from the nerve (6). Originally iso-
lated from the electric organ of Torpedo
californica based on its ability to cluster AChRs
upon addition to cultured myotubes (6), agrin
turned out to be the main organizer of the
NMJ. Agrin is synthesized by motorneurons,
transported along their axons, and released
into the extracellular milieu, leading to accu-
mulation in the synaptic basal lamina. In its
absence, in agrin-deficient knockout mice, dif-
ferentiated NMJs fail to form, and nerve-asso-
ciated clusters of AChRs and other
postsynaptic proteins are no longer observed
(7). Agrin’s crucial role in postsynaptic assem-
bly is further illustrated in microinjected
myofibers in vivo, where injection of agrin
cDNA causes the local formation of ectopic
postsynaptic specializations that contain clus-
tered AChRs in association with many other
postsynaptic proteins (8,9). Thus, agrin is both
necessary and sufficient to induce AChR clus-
tering and formation of the postsynaptic appa-
ratus. Finally, agrin may also play a role,
perhaps indirectly, in presynaptic differentia-
tion, because in agrin-deficient animals,
motorneurons grow extensively over muscle
fibers of the diaphragm without being
restricted to a central endplate zone (7). The
signaling pathway of agrin in muscle includes
the receptor tyrosine kinase (RTK) MuSK as a
key element and will be described below.
AChR transcription by myonuclei under-
neath the nerve terminal is induced at least in
part by neuregulin-1 (NRG-1), a protein
expressed by motorneurons and skeletal mus-
cle and concentrated at the NMJ (3,10). NRG-1
is a member of the neuregulin family of differ-
entiation factors and was originally isolated as
ARIA (AChR-inducing activity) from chick
brain extracts, based on its ability to induce
AChR gene expression in cultured myotubes
(10). As shown by heterozygous recombinant
mice lacking one copy of the NRG-1 gene,
NRG-1 is indeed necessary to maintain the
high synaptic density of AChRs in vivo (11).
NRG-1 acts by activating ErbBs (ErbB2-4),
members of the EGF receptor family of RTKs,
which are concentrated at the NMJ (12,13).
ErbB activation in turn triggers a generic sig-
naling cascade including kinases such as Ras,
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Raf, MAP kinases, and phosphatidylinositol-3-
kinase, as well as the adapter protein Shc and
the tyrosine phosphatase SHP2 (14–17).
Together, activation of these signaling interme-
diates culminates in enhanced transcription of
AChR genes in synaptic nuclei. This transcrip-
tion is thought to be mediated by binding of
members of the ets family of transcription fac-
tors, such as GABPα and GABPβ, to N-box
motifs in the regulatory regions of the AChR
subunit genes (18,19).
Interestingly, recent studies indicate that the
agrin and NRG-1 signaling pathways, which
both contribute to the high density of AChRs
in the postsynaptic membrane, are linked, and
that agrin acts upstream of NRG-1 in the for-
mation of the NMJ. Thus, besides clustering of
pre-existing AChRs, agrin can induce AChR
gene expression in cultured myotubes (20) and
in injected myofibers in vivo (21,22). Further-
more, NRG-1 binds to agrin in vitro, and agrin-
induced AChR gene transcription is dependent
on signaling through ErbB2 in cultured
myotubes (23). As ErbBs are no longer clus-
tered at mutant NMJs of mice lacking agrin (7),
these observations suggest that agrin acts
upstream of NRG-1 in postsynaptic differentia-
tion, by inducing clustering of NRG-1 recep-
tors, thereby enabling NRG-1 to locally
stimulate AChR gene transcription in subsy-
naptic nuclei.
MuSK, a Component of the Agrin Receptor
Despite a long-standing interest in the mech-
anisms of agrin signaling and postsynaptic
assembly, many steps in agrin-induced cluster-
ing of pre-existing AChRs remain uncertain. It
is clear, however, that neurally released agrin
activates a receptor in the muscle membrane,
which initiates a signaling cascade that ulti-
mately leads to clustering and anchoring of
AChRs via intracellular and AChR-associated
signaling and anchoring proteins (1,6). A key
component of the functional agrin receptor is
the RTK, MuSK. The crucial role of this RTK is
best illustrated by MuSK-deficient mice, which
lack differentiated NMJs, clusters of AChRs
and other postsynaptic proteins, and thus dis-
play a similar phenotype as agrin –/– mice
(24). Moreover, cultured MuSK –/– myotubes
fail to respond to agrin, whereas agrin triggers
a rapid tyrosine phosphorylation of MuSK
when added to wild-type muscle cells, further
showing that MuSK is a part of the agrin recep-
tor (25).
In analogy to certain other RTKs that require
co-receptors to bind to their extracellular lig-
ands, MuSK itself is unable to directly bind to
agrin (25). This observation has led to the pro-
posal that other proteins of myotubes (desig-
nated MASC, for myotube-associated
specificity component) associate with MuSK to
form a fully functional agrin receptor. The
nature of MASC, however, has remained
largely elusive, although MASC most likely
interacts with the first immunoglobulin-like
domain in the extracellular part of MuSK (26).
Based on its tight binding to agrin, α-dystro-
glycan, which is a component of the dys-
trophin/utrophin glycoprotein complex
(D/UGC), was originally proposed to form
part of a functional agrin receptor, thus being a
candidate for MASC. Subsequent studies have
shown, however, that agrin fragments that do
not bind to α-dystroglycan still induce AChR
clustering and activate MuSK (27–29), and that
agrin-induced MuSK activation is normal in
antisense-treated myotubes that express low
levels of α-dystroglycan (30). Thus, α-dystro-
glycan does not seem to be the MASC co-
receptor for MuSK.
Another important question is how, follow-
ing stimulation by agrin, MuSK transmits a
signal into myotubes. By analogy with other
RTKs, MuSK signaling is expected to involve
binding of signal-transducing molecules to
phosphorylated tyrosine residues in the cyto-
plasmic domain of agrin-activated MuSK. Fol-
lowing treatment with agrin, MuSK indeed
undergoes autophosphorylation, probably on
several cytoplasmic tyrosine residues (31). By
mutational analysis, two of these tyrosines
were found to be required for agrin-induced
AChR clustering in myotubes. One tyrosine is
located in the activation loop of the kinase
82 Huh and Fuhrer
Molecular Neurobiology Volume 25, 2002
domain, showing that the kinase activity of
MUSK is necessary for its responsiveness to
agrin (26,32). In addition, a juxtamembrane
tyrosine is required as well and can, along with
the sequences surrounding it, actually confer
agrin responsiveness when expressed in other-
wise inactive MuSK-TrkA chimeras (32). As the
juxtamembrane tyrosine occurs within an
NPXY sequence context, the consensus bind-
ing site for Shc and related adapter proteins,
one or several Shc-like proteins are likely to be
involved as downstream mediators in the
agrin signaling pathway.
Rapsyn, an AChR Clustering Protein
A central player in the agrin signaling path-
way downstream of MuSK is rapsyn. This pro-
tein was originally identified as a 43 kDa
protein in Torpedo synaptic membranes based
on its close association with AChRs (33). Rap-
syn is necessary for clustering of AChRs and
many aspects of postsynaptic differentiation in
muscle. Thus, rapsyn-deficient mice lack
aggregates of AChRs, dystroglycan, utrophin
and ErbB receptors, and cultured rapsyn –/–
myotubes do not form AChR clusters sponta-
neously nor even in response to agrin (34).
Because MuSK is still localized synaptically at
mutant NMJs in these mice and is tyrosine-
phosphorylated by agrin in rapsyn –/–
myotubes, rapsyn clearly acts downstream of
MuSK (35).
The mechanism of rapsyn-dependent clus-
tering of AChRs has been extensively ana-
lyzed by protein expression in heterologous
cells. In transfected nonmuscle cells, rapsyn
causes clustering of itself, and, upon co-
expression, of AChRs and certain other post-
synaptic proteins such as MuSK or
dystroglycan. This suggests that rapsyn is a
general mediator of protein clustering
(36–38). Rapsyn has a unique protein struc-
ture in which an N-terminal myristoylation
site is followed by eight tetratricopeptide
repeats (TPR), a coiled-coil motif, a ring zinc-
finger motif, and a serine phosphorylation
site (reviewed in ref. 39). By heterologous
expression, some of these domains were
found to mediate distinct aspects of rapsyn
functioning. First, N-terminal myristoylation
mediates targeting of rapsyn to the plasma
membrane (40,41). Second, at least two of the
eight TPRs are necessary and sufficient for
self-association of rapsyn as clusters in trans-
fected cells, whereas, third, the coiled-coil
motif is required for co-clustering of AChRs
in rapsyn aggregates (40,42). Furthermore,
rapsyn clusters each of the AChR subunits in
heterologous cells and requires the intracellu-
lar portion of the subunit for this, as shown
by the AChR α subunit (43). Together, these
recent studies suggest that rapsyn interacts
with the cytoplasmic moieties of all subunits
of the AChR and that rapsyn self-association
and rapsyn-induced AChR clustering are
mediated by different domains in rapsyn.
Rapsyn also causes clustering of MuSK and
dystroglycan upon co-expression in QT-6 cells,
and biochemical evidence shows that rapsyn
directly binds to the cytoplasmic portion of 
β-dystroglycan (44). In the case of MuSK, the
interaction, unexpectedly, does not depend on
the cytoplasmic tail of MuSK, but involves the
fourth immunoglobulin-like domain in
MuSK’s exodomain, leading to the concept
that a rapsyn-associated transmembrane linker
protein (RATL) links rapsyn to the exodomain
of MuSK (Fig. 1; 26,35). This linker, whose
identity remains unsolved, may recruit rapsyn
and its associated proteins to MuSK and
thereby play a crucial role in agrin signaling.
These results are largely based on studies
performed using heterologous cell systems
and may not be entirely applicable to
myotubes, where clustering is regulated in dif-
ferent and/or additional ways: in myotubes,
efficient AChR clustering requires agrin and
MuSK, and the clusters are much larger. In
myotubes, indeed, the expression level of rap-
syn is an important parameter that deter-
mines its ability to mediate agrin-induced
AChR clustering. Endogenous rapsyn nor-
mally occurs in about a 1:1 stoichiometry with
the AChR in muscle (45). Upon overexpres-
sion of rapsyn in wild-type or rapsyn –/–
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myotubes, fewer spontaneous and agrin-
induced AChR clusters are seen than in cells
expressing physiological levels of rapsyn
(46,47). This effect appears to originate from
intracellular accumulation of AChRs in the
case of high rapsyn expression, implying a
role of rapsyn in trafficking of AChRs to the
plasma membrane (48). Consistent with such
a role, rapsyn was recently colocalized with
AChRs in post-Golgi transport vesicles of Tor-
pedo electric organ (49). Another example
illustrating the differences between heterolo-
gous and muscle cells is the zinc ring finger
domain of rapsyn, which is dispensable for
rapsyn-induced AChR clustering in heterolo-
gous cells but not for spontaneous AChR
aggregation in myotubes (42,50). These stud-
ies suggest that in myotubes, rapsyn function-
ing depends on interaction with other, as yet
unidentified muscle-specific proteins.
Downstream Agrin Signaling: a Role 
of AChR β Phosphorylation 
and Src-Family Kinases
Prominent other steps in the agrin signaling
pathway downstream of MuSK are tyrosine-
phosphorylation of the AChR and a link of the
AChR to the cytoskeleton. Four recent studies
now show that phosphorylation of the AChR β
subunit and Src-family kinases play a role in
these processes and hence for formation and
stabilization of AChR clusters (51–54).
In myotubes in culture, agrin induces tyro-
sine phosphorylation of the AChR β and δ sub-
units as well as a link of the AChR to the
cytoskeleton, as shown by AChR extraction
assays (52,55, 56). Also, developing NMJs in
vivo contain phosphotyrosine-proteins that
codistribute with AChRs, and AChRs at these
junctions are progressively stabilized, presum-
ably through a link to cytoskeletal elements
(57,58). In agrin-treated myotubes, AChR β
and δ phosphorylation occur early before clus-
ters are visible (52); β phosphorylation is paral-
leled by decreased extractability of the AChR,
which also precedes clustering (55). Several
strategies have been applied to determine
whether the AChR phosphorylation induced
by agrin plays a role in AChR clustering and
cytoskeletal linkage. For example, inhibitors of
tyrosine kinases, such as herbimycin and stau-
rosporine, block both agrin-induced AChR β
and δ phosphorylation and clustering (52,56,
59). Conversely, increasing AChR phosphory-
lation by treatment of myotubes with pervana-
date causes an increased cytoskeletal link of
AChRs (60). Most importantly, when mutated
AChRs, lacking cytoplasmic tyrosine residues
in their β subunits, are expressed in transfected
myotubes, they are still able to form agrin-
induced clusters (61), but the extent of cluster-
ing and their cytoskeletal linkage are clearly
reduced when compared to wild-type AChRs
(51). Thus, agrin-induced phosphorylation of
the AChR β subunit regulates the link of the
AChR to the cytoskeleton and contributes to
clustering of AChRs.
Another issue is which kinase(s) causes
phosphorylation of the AChR subunits in
response to agrin and what role such a kinase
plays in agrin-induced AChR clustering.
MuSK is unlikely to directly phosphorylate
the AChR, as illustrated in rapsyn –/–
myotubes and staurosporine-treated wild-
type myotubes, in which agrin activates
MuSK, whereas AChR β and δ phosphoryla-
tion and clustering are blocked (35,52,62).
These studies strongly imply the existence of
some other kinase(s) downstream of MuSK.
Accumulating evidence suggests that this
kinase(s) is a member of the Src-family: first,
Src and Fyn are associated with AChRs in
myotubes (63), whereas Fyn and Fyk are
major kinases in Torpedo electric organ and
associate with AChRs in this tissue (64,65).
Second, Src can phosphorylate AChR β fusion
proteins containing the tyrosine residue that
is phosphorylated in agrin-treated myotubes
(51,63). Third and most importantly, AChR-
bound Src family members are activated and
tyrosine-phosphorylated in agrin-treated
myotubes, and this activation is abolished by
staurosporine and not observed in rapsyn-
deficient myotubes, and thus correlates
84 Huh and Fuhrer
Molecular Neurobiology Volume 25, 2002
highly with AChR clustering (52). Fourth,
similarly, each of the Src family kinases Src,
Fyn and Fyk can interact with rapsyn in trans-
fected fibroblasts, leading to an activation of
these kinases and phosphorylation of cotrans-
fected AChRs (66). Fifth, Src and Fyn form a
complex with MuSK in myotubes, are able to
phosphorylate MuSK, and their binding to
MuSK depends on their SH2 domain and is
increased by agrin (53). Sixth, of significance,
in myotubes, the agrin-induced linkage of
AChRs to the cytoskeleton is blocked by a
specific inhibitor of the Src family, PP1, and
agrin-induced AChR clustering is reduced by
expression of dominant-negative, kinase-inac-
tive Src, resulting in AChR aggregates that are
very small (53). Finally, by using knockout
mice, the role of Src and Fyn in postsynaptic
differentiation, AChR clustering and phos-
phorylation was directly tested (54). In mice
lacking Src and Fyn, all aspects of synaptic
development examined such as innervation,
AChR gene expression, and clustering of
postsynaptic proteins are normal until around
birth, by which time these animals die (54). In
cultured Src-Fyn-deficient myotubes derived
from these mice, agrin causes normal AChR
clustering and AChR β phosphorylation, and
the Src-family kinase Yes is upregulated.
Interestingly, following withdrawal of agrin,
agrin-induced clusters of AChRs are dramati-
cally less stable in myotubes lacking Src and
Fyn than in wild-type cells (54).
Together, these recent studies show that
kinases of the Src family play a role in agrin
signaling: they interact with MuSK in an agrin-
dependent manner and are activated by agrin
locally, when bound to the AChR. Further,
their functioning is required to link the AChR
to the cytoskeleton and for growth of AChR
clusters. Src and Fyn themselves, however, are
dispensable for AChR clustering and phospho-
rylation, although, in their absence, Yes may
compensate. Nonetheless, Src and Fyn are
clearly required to stabilize agrin-induced
AChR aggregates, showing that the mecha-
nisms for formation vs stabilization of these
clusters are different.
Protein Interactions and Steps 
in Formation of the Postsynaptic
Apparatus: Evidence for Postsynaptic
Pre-Assembly
Src-family kinases interact both with MuSK
and the AChR in myotubes. In both cases,
some interaction occurs before addition of
agrin, thus revealing the existence of pre-
assembled protein complexes. However, these
interactions appear to reflect two distinct pools
of Src-family kinases that respond differently
to treatment with agrin. Thus, agrin causes Src
members to increasingly bind to MuSK (53),
but activates AChR-associated Src kinases
without affecting their interaction with AChRs
(52). Furthermore, agrin induces MuSK phos-
phorylation independently of rapsyn (35),
implying that Src-mediated MuSK phosphory-
lation (53) does not require rapsyn. In contrast,
activation of AChR-bound Src members by
agrin critically depends on rapsyn (52). There-
fore, there is increasing evidence for the exis-
tence of two independent pre-assembled
signaling complexes in myotubes, a MuSK-
bound complex and an AChR-bound complex
(Fig. 2).
How do these complexes contribute to post-
synaptic assembly? The available evidence
suggests that the MuSK-bound complex acts
as a primary synaptic scaffold and is clustered
first due to agrin; this scaffold then recruits
pre-assembled AChR complexes via rapsyn
(Fig. 2). These steps of postsynaptic assembly
are based, first, on the observation that MuSK
is the only identified postsynaptic protein to
still be clustered at mutant synapses of rap-
syn-deficient mice (35). In addition, when
expressed ectopically in injected muscle fibers
in vivo, a constitutively active form of MuSK
is able to organize postsynaptic specializations
containing AChRs in association with most
other postsynaptic components (67). Second,
rapsyn induces aggregation of AChRs, dystro-
glycan, MuSK, and of itself when expressed in
heterologous cells (36–38), suggesting that
rapsyn recruits other postsynaptic compo-
nents to the MuSK scaffold. Third, in cultured
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myotubes, AChRs interact with rapsyn,
MuSK, Src-family kinases, dystroglycan, and
utrophin independently of agrin, showing that
diffusely distributed AChRs can pre-assemble
pools of postsynaptic components including
rapsyn (68). Such complexes associate with
MuSK—presumably the MuSK primary
synaptic scaffold—in response to agrin, lead-
ing to a rapsyn-dependent increase in the
AChR-MuSK interaction, whereas other
AChR-protein interactions are not affected by
agrin (Fig. 2; 68). Fourth, intracellular AChRs
of Torpedo electric organ are colocalized with
rapsyn, dystroglycan, and syntrophin in post-
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Fig. 2. Steps in the assembly of the postsynaptic membrane at the NMJ. (A) In the absence of nerve-derived
agrin, at least two pre-assembled signaling complexes exist in the muscle membrane, an AChR complex and
a MuSK complex. Assembly of these complexes may in part occur in the secretory pathway, since some of
their components colocalize in post-Golgi vesicles. Two main local signaling events leading to AChR cluster-
ing in response to agrin are depicted. In the MuSK complex, which may act as a primary synaptic scaffold,
agrin causes rapid activation of MuSK and recruitment of Src and Fyn to MuSK, leading to MuSK phosphory-
lation. In the AChR complex, agrin activates MuSK rapidly; in a rapsyn-dependent way, AChR-bound Src and
Fyn are then autophosphorylated, and AChR β and δ subunits are tyrosine-phosphorylated. Further elements
involved are Calcium fluxes, activation of Rac and Cdc42, NO and actin filaments, which are all required for
formation of AChR clusters. (B) After prolonged treatment with agrin, clusters of postsynaptic proteins are
formed, at least in part by a rapsyn-dependent linkage of the pre-assembled AChR complexes shown in (A) to
the MuSK complex/primary synaptic scaffold. α-DG, α-dystroglycan; p, tyrosine phosphorylation.
Golgi transport vesicles, implying that some
formation of pre-assembled AChR complexes
may occur intracellularly (69).
Taken together, these studies imply an active
functional role of AChRs in synaptic assembly.
Consistent with this idea, agrin does not
induce clusters of acetylcholinesterase in
myotubes where AChRs were downregulated
with anti-AChR antibodies (70). Further, agrin-
induced clustering of a full set of postsynaptic
markers requires the presence of AChRs in
myotubes, as shown recently in derivatives of
C2 myotubes expressing low levels of AChRs,
as well as by using C2 myotubes in which sur-
face AChRs were downregulated by anti-
AChR antibodies (71a). In particular, after
downregulating AChRs by treating with anti-
bodies, clusters of rapsyn were not produced
in response to agrin (71a). Thus, accumulating
evidence suggests that AChRs play an active
and early role in postsynaptic assembly, at
least in part by forming complexes with other
postsynaptic components, which are pre-
assembled prior to the treatment of agrin (Fig.
2).
Other Signaling Intermediates in Agrin-
Induced AChR Clustering: Calcium,
GTPases, and nNOS
Agrin-induced postsynaptic assembly
(Fig. 2) is likely to be regulated by additional
signaling intermediates. Calcium fluxes are
required for AChR clustering, as shown by
inhibition of agrin-induced AChR clustering by
the fast calcium chelator, BAPTA-AM (72). Fur-
thermore, Rac and Cdc42 are necessary for
agrin-induced clustering of AChRs in
myotubes, because dominant-negative forms of
these small GTPases inhibit aggregation of
AChRs in transfected myotubes (73). Rac and
Cdc42 are known from other systems to control
actin polymerization, for example, causing
focal reorganization of the actin cytoskeleton in
response to extracellular cues. Indeed, latrun-
culin A inhibits agrin-induced AChR clustering
in cultured Xenopus muscle cells, confirming
the importance of F-actin assembly in AChR
aggregation (74). It is unclear, however, how 
F-actin acts in AChR clustering. A synaptic
component of the D/UGC, utrophin, binds to
actin but is dispensable for AChR clustering
(75), implying that actin acts through other
binding proteins.
Another signaling mediator that was
recently recognized to play a role in agrin-
induced AChR aggregation is nitric oxide, NO
(76). Neuronal nitric oxide synthetase, nNOS,
was known for several years to be concen-
trated at NMJs, through binding to isoforms of
syntrophin, components of the D/UGC (1).
Recently, nNOS was found to be co-clustered
with AChRs in agrin-treated cultured
myotubes (77), and NO was identified as a
downstream mediator in agrin-induced AChR
clustering and AChR β phosphorylation, as
shown by using NOS inhibitors and NO
donors (76). The targets of NO could, in princi-
ple, involve Src family kinases, as these are
activated by NO in fibroblasts; this idea is
attractive because of the activation of Src-fam-
ily kinases by agrin in myotubes and their role
in stabilization of AChR clusters (52,54).
AChR Clustering by Laminin
Besides agrin, a number of other factors
stimulate AChR clustering when added to cul-
tured muscle cells. These include laminin
(78,79) and VVA-B4, a lectin that binds
synapse-specific carbohydrates (80). In addi-
tion, basic fibroblast growth factor (bFGF) and
heparin-binding growth-associated molecule
are also active in clustering when bound to
polystyrene beads (81,82). The relevance of
many of these factors for AChR clustering and
NMJ development in vivo is unclear. However,
laminin is of particular interest, as it is present
synaptically throughout formation of the NMJ
and colocalizes with AChR clusters both in
vivo and in vitro (83), suggesting that laminin
may provide a supplemental pathway for
AChR clustering besides agrin. In the adult,
laminin is a major component of the muscle-
fibre basal lamina, with distinct synaptic and
extrasynaptic isoforms. Laminin molecules are
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heterotrimers composed of three chains, α, β,
and γ, which exist in multiple forms encoded
by separate genes, giving raise to many
laminin isoforms. The basal lamina at mature
NMJs contains three major laminin forms,
laminin-4 (α2β2γ1), laminin-9 (α4β2γ1), and
laminin-11 (α5β2γ1) (Fig. 1), whereas laminin-2
(α2β1γ1) is the predominant extrasynaptic iso-
form found in adult muscle and transiently
present at developing NMJs (84). Laminin-1
(α1β1γ1), in turn, is expressed early in skeletal
muscle development and around the time of
initial synapse formation. A crucial role in neu-
romuscular synaptogenesis has been shown
for the β2 chain. In β2-deficient mice, synaptic
organization is aberrant: postsynaptic folds are
reduced, the number of active zones in the
nerve terminal is decreased, and Schwann cells
extend processes into the synaptic cleft (85).
Schwann cell intrusion originates from the
absence of laminin-11, which normally pre-
vents Schwann cell entry by inhibiting growth
of their processes (86).
Binding of agrin to laminin appears to form
the basis for the localization and tight associa-
tion of agrin with the muscle basal lamina. The
N-terminal portion of the major isoform of
agrin in the PNS, designated as the NtA
domain (87,88), binds with high affinity to
laminin-1, -2, and particularly well to the
synaptic laminin-4 (89). Binding occurs
through the coiled coil domain of the γ1 chain
(90,91). This binding may thus contribute to
synaptic localization of agrin and suggests that
both laminin and agrin act together in synaptic
development.
Laminin-1 and merosin (laminin-2/4) cluster
AChRs when added to cultured myotubes
(78,79,92). The laminin signaling pathway is dif-
ferent from that of agrin and does not involve
MuSK or tyrosine phosphorylation of AChRs
(78,79). Laminin-induced AChR clustering
occurs with a slower time-course and leads to
higher densities of AChRs in clusters than in the
case of agrin. Moreover, the laminin clustering
pathway involves dystroglycan, as shown both
in antisense myotube derivatives expressing
very low amounts of dystroglycan, and in
myotubes differentiated from dystroglycan –/–
embryonic stem cells, where laminin fails to
cause AChR aggregation (78,93). Laminin sig-
naling may also involve integrins, because α7β1
integrins are coclustered with AChRs in
response to laminin, and as anti-α7 antibodies
modulate the AChR clustering ability of laminin
(Fig. 1; 94). This is consistent with the postsy-
naptic localization of several forms of these
receptors at endplates, in particular, α3, α7, αv,
and β1 (5). Interestingly, integrins are also sug-
gested to act as modulators in agrin signaling,
in particular, the αvβ1 heterodimer (95), based
on antibody inhibition experiments. In addition,
cells overexpressing αv and β1 integrin adhere
to agrin, revealing a possible binding of agrin to
this particular integrin.
Thus, integrins, in particular those contain-
ing β1, appear to be involved in laminin as well
as agrin signaling. Accordingly, besides their
differences, agrin and laminin share some of
their signaling mechanisms, explaining the
additive effects of agrin and laminin on AChR
clustering in myotubes (79). Together, these
studies indicate that agrin and laminin can act
in concern to lead to maximal AChR cluster-
ing, which may be important for postsynaptic
differentiation at the NMJ in vivo.
Role of Oligosaccharides in AChR
Clustering
Carbohydrates that terminate in N-acetyl-
galactosamine (βGalNAc) are selectively
enriched at the NMJ and react with specific
lectins such as VVA-B4 (80). Recent studies
have shown that several factors that bind to
and/or modify oligosaccharides, preferen-
tially complex-type N-linked sugars, can
induce AChR clustering in cultured myotubes,
thus raising the possibility that such oligosac-
charides contribute to AChR aggregation dur-
ing formation of the NMJ in vivo. These
factors include VVA-B4, neuraminidase, and
α-galactosidase (80,96,97). While VVA-B4 acts
via a pathway independent of MuSK and
AChR phosphorylation, possibly via α-dystro-
glycan (98), neuraminidase increases MuSK
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and AChR phosphorylation, indicating that
oligosaccharides may be involved both in
agrin-dependent and agrin-independent
mechanisms of AChR clustering. Of particular
interest are VVA-B4-reactive sugars containing
βGalNAc. At the NMJ, βGalNAc occurs in the
context of a defined oligosaccharide struc-
ture, the CT carbohydrate antigen, which con-
tains the disaccharides Galβ1,3GalNAc and
Galβ1,4GlcNAc as prominent components
(99). Both of these disaccharides induce AChR
clustering in myotubes as well as MuSK
autophosphorylation in vitro, as shown by in
vitro phosphorylation assays (99). Interest-
ingly, agrin contains a mucin-like domain to
which lactosamine-like saccharides are
attached. Fragments of agrin containing the
mucin domain stimulate MuSK autophospho-
rylation in vitro, which can be inhibited by
adding Galβ1,3GalNAc or Galβl,4GlcNAc.
Finally, these disaccharides bind to agrin and
MuSK in vitro (99).
The CT antigen thus can serve a similar
function to that proposed for the MuSK co-
receptor MASC, since it can bind to agrin and
MuSK, and stimulate the MuSK kinase activity.
Therefore, the CT carbohydrate may act as
MASC. It remains to be determined on which
protein the active CT carbohydrates are pre-
sent, and which protein(s) are recognized by
VVA-B4 at NMJs in vivo.
Stabilization of AChR Clusters and
Maturation of the Postsynaptic
Apparatus
During development of the NMJ, AChR
clusters are formed rapidly after contact
between motorneuron and muscle. At birth,
clustered AChRs are homogenously arranged
in a flat postsynaptic membrane underneath
the nerve, muscle fibers are multiply inner-
vated, and several nerve terminals are inter-
mingled over the postsynaptic apparatus (1).
In the first weeks of postnatal development,
competitive mechanisms between these
motoneurons lead to synapse elimination.
Another aspect of postnatal maturation is the
formation of postjunctional folds, leading to
segregation of some proteins to become con-
centrated either at the crests or in the troughs
of these folds. AChRs, for example, are local-
ized at the crests, whereas sodium channels are
located in the troughs. Using knock-out mice,
recent studies indicate that components of the
D/UGC, while largely dispensable for initial
AChR clustering, are essential both for consoli-
dation and stabilization of AChR clusters as
well as for formation of postjunctional folds.
The D/UGC is Required for Stabilization
of AChR Clusters and Postnatal
Maturation of the Postsynaptic
Membrane
The D/UGC links the cytoskeleton of mus-
cle fibers to their extracellular matrix and
thereby stabilizes the muscle sarcolemma
(100). Differential localization of members of
the complex gives rise to synaptic and extrasy-
naptic variants of the D/UGC. At NMJs,
utrophin, β2-syntrophin, and α-dystrobrevin-1
are highly concentrated and virtually absent
from extrasynaptic areas, whereas α-syn-
trophin, α-dystrobrevin-2, α- and β-dystrogly-
can, and dystrophin are found both at NMJs
and extrasynaptic areas (38,101,102). Addi-
tional components of the complex, the sarco-
glycans and sarcospan, are found synaptically
and extrasynaptically as well (100). Extracellu-
lar binding partners for the synaptic D/UGC
are agrin and laminin isoforms (laminin chains
β2, α5, and α4), which are all concentrated at
NMJs (Fig. 1). The largest components of the
D/UGC, utrophin and dystrophin, are neces-
sary for the integrity of muscle fibers but
largely dispensable for NMJ formation.
Utrophin-deficient mice have a surprisingly
mild phenotype in that they appear healthy
and viable, and have functional NMJs (75,103).
The density of synaptic AChRs is slightly
reduced, and formation of postjunctional folds
after birth is less pronounced. Likewise, NMJs
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of mdx mice, which lack functional dystrophin,
are largely normal, apart from a reduced num-
ber of postsynaptic folds. This reduction may
result from muscle-fiber necrosis and cycles of
regeneration rather than from the absence of
dystrophin per se (104,105). These relatively
minor effects on morphology of the NMJ in
utrophin –/– and mdx mice could, in principle,
be due to partial compensation between the
two proteins. Accordingly, double-deficient
mice lacking both dystrophin and utrophin
develop a severe muscular dystrophy closely
resembling human Duchenne muscular dys-
trophy (106,107). However, even in these ani-
mals, NMJs are remarkably normal, displaying
subtle postsynaptic defects such as reduced
AChR density and less postsynaptic folds. This
suggests that the D/UGC as such is not essen-
tial for formation of the NMJ and AChR clus-
ters, but rather for their maturation, in
particular, formation of postsynaptic folds.
A component of the D/UGC involved in
consolidation and maintenance of AChR clus-
ters and the NMJ is dystroglycan (Table 1). As
dystroglycan-deficient mice die at E6.5, before
muscles are formed, chimaeric mice were gen-
erated by injecting dystroglycan –/– embry-
onic stem cells into blastocytes of wild-type;
these chimeras lack dystroglycan in many stri-
ated muscles (108). Dystroglycan-deficient
muscles of these mice develop severe muscular
dystrophy and, in adult animals, NMJs are
fragmented and lack the typical high density
of AChRs and AChEsterase. Instead, AChRs
are distributed over an increased area, with a
coordinate increase in nerve terminal size at
these junctions (93). Agrin-induced AChR clus-
tering was analyzed by using myotubes gener-
ated from dystroglycan –/– embryonic stem
cells. Agrin still induces substantial AChR
clustering in these cells, but utrophin, α-dys-
trobrevin, laminin chains, perlecan, and
AChEsterase are not found at these clusters
(93,109). As in vivo in chimaeric mice, the area
of agrin-induced AChR clusters is increased in
dystroglycan –/– myotubes, and the clusters
actually consist of many microclusters and dis-
perse rapidly after withdrawal of agrin. Simi-
larly, formation of AChR clusters of normal
size is severely compromised in antisense
derivatives of C2 myotubes expressing low
amounts of dystroglycan (30). As phosphoryla-
tion of MuSK and AChR β subunits is
unchanged in these antisense cell lines, dystro-
glycan and the D/UGC as such are not neces-
sary for AChR clustering per se, and
dystroglycan is not a coreceptor for MuSK.
Overexpression of dystroglycan can decrease
AChR clustering at developing Xenopus
NMJs, however, most likely by adsorbing agrin
and preventing it form normal signaling via
MuSK (110). Together, these data indicate that
dystroglycan is required for integrity of the
D/UGC and serves as a membrane anchor to
recruit components of the complex to the
plasma membrane. Furthermore, dystroglycan
is required for consolidation of AChR micro-
clusters into clusters of normal size and for sta-
bilization of AChR aggregates and the NMJ.
Similarly, α-dystrobrevin isoforms are neces-
sary to stabilize AChR clusters (Table 1). Mice
deficient for α-dystrobrevin develop muscular
dystrophy due to the absence of D/UGC-
linked signaling by nNOS, which normally
binds to dystrobrevin (111). At the NMJ of
these animals, initial synapse formation pro-
ceeds relatively normally, but postnatal matu-
ration is affected, because less postsynaptic
folds are formed and contain AChRs at crests
as well as in troughs, and because AChR-rich
areas become fragmented in older animals
(109). Synaptic localization of dystrobrevin-
binding proteins such as α- and β2-syntrophin
or nNOS, but not other D/UGC components,
is reduced in the mutants. Finally, in cultured
myotubes, agrin induces normal clustering of
AChRs, but these clusters disperse rapidly
upon withdrawal of agrin (109). Dystrobrevin
is thus necessary for stabilization of AChR
clusters in vitro and in vivo and for formation
of postsynaptic folds with characteristic segre-
gation of AChRs between crests and troughs.
As NMJs in triple knockout mice lacking
utrophin, dystrophin, and α-dystrobrevin are
not dramatically different from single dystro-
brevin knockouts (109), essential synaptic
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functions of the D/UGC seem to be mediated
by dystrobrevin, probably by localizing its
associated signaling molecules to the NMJ.
Finally, absence of α-syntrophin leads to
structurally aberrant synapses (112). The iso-
forms of syntrophin show differential localiza-
tion at the adult NMJ. Whereas α-syntrophin is
found at the crests and in the troughs of post-
synaptic folds, β2-syntrophin occurs mainly in
the troughs; the β1 isoform is not concentrated
at the NMJ (102). In the absence of α-syn-
trophin, muscle fibers appear healthy histolog-
ically and the mice are mobile and fertile (113).
NMJs of these animals lack utrophin and
nNOS, have reduced levels of AChRs and
AChEsterase and show abnormal postsynaptic
folds with fewer openings to the synaptic cleft
(112). α-syntrophin thus mediates localization
of utrophin and nNOS to the NMJ, and the
similarities in NMJs between α-syntrophin-
and utrophin-deficient mice suggest that α-
syntrophin functions to localize utrophin at the
synapse, which organizes postsynaptic fold
formation.
Together, studies on knockouts of compo-
nents of the D/UGC show that this complex is
largely dispensable for initial formation of
AChR clusters and the NMJ. Instead, the com-
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Table 1
Proteins Necessary for Stabilization of AChR Clusters
Effect of absence
Protein of active protein Experimental approach Reference
Dystroglycan Fragmentation of postsynap-
tic membrane, muscular
dystrophy
Chimaeric mice lacking
dystroglycan in some
muscle fibers
Cote et al., 1999
(108); Jacobson
et al., 2001 (93)
Rapid dispersal of frag-
mented AChR clusters
Withdrawal of agrin from
agrin-treated dystroglycan-
deficient myotubes
Dystrobrevin Fragmentation of postsynap-
tic membrane, less
postjunctional folds, mus-
cular dystrophy
α-dystrobrevin –/– mice Grady et al., 1999,
2000 (111,109)
Rapid dispersal of AChR
clusters
Withdrawal of agrin from
agrin-treated α-dystro-
brevin –/– myotubes
Src and Fyn Normal NMJ around birth Src-Fyn-deficient mice Smith et al., 2001
(54)
Rapid dispersal of AChR
clusters
Withdrawal of agrin from
agrin-treated src –/–; fyn
–/– myotubes
TrkB Disruption of AChR clusters
at the NMJ
Adenovirus-mediated expres-
sion of dominant-negative
TrkB in muscle in mice
Gonzalez et al.,
1999 (118)
Disruption of AChR clusters Adenoviral expression of
dominant-negative TrkB in
agrin-treated myotubes
plex is mainly required for postnatal matura-
tion of the postsynaptic membrane as well as
for stabilization of AChR clusters.
Tyrosine Kinases Are Required for
Stabilization of Agrin-Induced 
AChR Clusters
Three lines of evidence have recently indi-
cated that, in addition to the D/UGC, tyrosine
kinases are important for the stability of agrin-
induced AChR clusters. First, upon removal of
agrin, the kinase inhibitors herbimycin and
staurosporine disperse pre-formed AChR clus-
ters in myotubes (56), showing that tyrosine
kinase activity is necessary to maintain AChR
clusters. This activity most likely originates
from another kinase than MuSK, because stau-
rosporine does not affect the autophosphoryla-
tion of MuSK (62).
Second, Src and Fyn mediate stabilization
of AChR clusters, because in myotubes cul-
tured from Src-Fyn-doubly deficient mice,
agrin induces normal phosphorylation and
aggregation of AChRs, but these clusters dis-
perse rapidly after withdrawal of agrin (54).
Src and Fyn are thus dispensable for AChR
clustering, but essential for cluster stabiliza-
tion. PP1 and PP2, inhibitors of Src-family
kinases, do not decrease the stability of AChR
aggregates, suggesting that cluster stabiliza-
tion does not primarily require the kinase
activities of Src and Fyn, but rather their pres-
ence as adapters, by mediating protein inter-
actions (54; Table 1). These findings reveal
interesting parallels to focal adhesion sites,
where Src, independent of its kinase activity,
can recruit and activate other proteins such as
focal adhesion kinase (FAK) (114,115). Fur-
thermore, multiple tyrosine kinases, includ-
ing Src, FAK, and Pyk2, can complement each
other to achieve optimal adhesion on
fibronectin (116), raising the possibility that
interaction of multiple kinases may regulate
interactions between the postsynaptic mem-
brane and cytoskeleton elements at the NMJ,
thereby stabilizing AChR clusters. In support
of this, several cytoskeletal proteins such as
talin, paxillin, and α-fodrin can be tyrosine-
phosphorylated and are concentrated at the
mammalian NMJ or in Torpedo synaptic
membranes (117).
Third, TrkB is also involved in cluster stabi-
lization. Disruption of TrkB-mediated signal-
ing, by overexpression of a dominant-negative
form of TrkB, decreases the stability of AChR
clusters in vivo and in agrin-treated cultured
myotubes (Table 1; 118). TrkB is localized to
the postsynaptic membrane in muscle and
can associate with Fyn in cortical neurons
(118,119), raising the possibility that TrkB sig-
naling mediated by Src-family kinases stabi-
lizes AChR clusters in muscle. The ligand for
TrkB mediating this effect is not known.
BDNF, a prominent ligand of TrkB, and NT-4
inhibit agrin-induced AChR clustering in cul-
tured myotubes (120). TrkB may thus exert
two different effects at the NMJ, depending
on the stage of NMJ differentiation. Early in
postsynaptic assembly, it may—stimulated by
BDNF—negatively regulate AChR clustering,
while later it stabilizes the postsynaptic mem-
brane.
Together, these studies show that several
tyrosine kinases, at least Src, Fyn, and TrkB, are
involved in stabilization of AChR clusters. The
mechanisms for formation vs stabilization of
AChR clusters are thus different, both in terms
of structural proteins, as reflected by the
D/UGC, as well as in their requirement for sig-
naling proteins, as shown in the case of Src,
Fyn, and TrkB. It remains to be determined
whether and how tyrosine kinases and the
D/UGC collaborate to achieve optimal stabi-
lization. One possible link is dystrobrevin,
which is a substrate for tyrosine kinases and
strongly tyrosine-phosphorylated in Torpedo
electric organ (121). Although α dystrobrevin
is neither required for early steps in agrin-
induced AChR clustering nor tyrosine-phos-
phorylated by agrin stimulation (101), its
phosphorylation may play a role in stabiliza-
tion of AChR clusters at the developing NMJ.
This would be consistent with the striking sim-
ilarity in dispersal of AChR clusters in dystro-
brevin –/– and Src-Fyn-deficient myotubes, as
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well as in muscle cells overexpressing domi-
nant-negative TrkB (Table 1).
A Role of AChRs in Postsynaptic
Stabilization
During postnatal NMJ development, the
composition of AChRs changes, as the embry-
onic γ subunit is replaced by the adult ε chain.
By deleting the ε gene in mouse, the role of
AChRs in this phase of NMJ development was
analyzed. In ε –/– mice, the high postsynaptic
density of AChRs is gradually reduced in the
first weeks after birth, as these animals fail to
synthesize adult-type AChRs (122,123). Conse-
quently, the mice develop gradual muscle
weakness and atrophy, and die prematurely.
Along with the reduced AChR density,
postjunctional folds disappear, in such a way
that the postsynaptic membrane, although rich
in folds at 20 d, is flattened out by 60 d of age
(124). Further, postsynaptic components such
as rapsyn, utrophin, MuSK, erbB4, phosphoty-
rosine, and dystrobrevin are reduced as the
AChR density decreases (122,124). Interest-
ingly, rapsyn disappears strictly in parallel
with AChRs, while utrophin and dystrobrevin
lag behind (124). Thus, ε-containing AChRs are
required for synaptic localization of rapsyn
and maintenance of the postsynaptic appara-
tus at the postnatal NMJ, including postjunc-
tional folds.
In addition, activity through the AChR is
necessary to maintain its high synaptic density
(125). In adult mice, AChRs are highly meta-
bolically stabilized, displaying a half-life of
about 14 d. Immediately after blocking AChRs
by α-bungarotoxin (BTX), the half-life is
reduced to less than a day, resulting in rapid
turnover of postsynaptic AChRs and a
decrease in the density of postsynaptic AChRs.
This decrease in half-life can be stopped by
direct stimulation of muscle or restoration of
synaptic transmission (125). These data indi-
cate that AChR activation is required for its
synaptic stability and that AChRs serve struc-
tural roles in maintaining the postsynaptic
apparatus. AChRs thus appear to be necessary
for both formation and maintenance of the
postsynaptic apparatus at the NMJ.
Nicotinic Receptors 
in the Nervous System
Multiple classes of neurotransmitter recep-
tors localized at the synapse of a neuron and
different setup of synaptic excitability of target
cells suggest that synaptic features, which
have been characterized in the muscle, might
not simply be translated into the nervous sys-
tem. Differently from the muscle type, nico-
tinic receptors in the nervous system are
characterized by high Ca2+ permeability and
considerable diversity of their subunits. So far,
nine different α (α2,3,4,5,6,7,8,9,10) and three dif-
ferent β subunits (β2,3,4) have been identified in
vertebrates, which are encoded by distinct
genes (126–128). Differential splicing of some
of the genes further extends this already exist-
ing list of clones (129).
Functional subtypes of receptors that can be
generated from different arrays of subunits are
equally diverse although they all appear to
form a pentameric structure (127,130). α7, α8,
and α9 subunits form a homo-oligomeric com-
plex when expressed as a single subunit and
comprise the α-bungarotoxin (BTX)-binding
class of AChRs. The α7 subunit is one of the
most abundant subunits that are expressed in
the vertebrate nervous system and α7 receptors
are characterized by high Ca2+ permeability
that is comparable to NMDA receptor channels
(131,132). Other subunits require α or β to be
functional as a hetero-oligomer. Prominent
examples are α4β2, which is the most abundant
subtype in the brain and forms high-affinity
nicotine binding sites, and ganglionic subtypes
of receptors containing α3, α5, β2, and β4.
Expression of multiple subunit genes in the
same neuronal population suggests that, in
reality, the profile of subtypes of neuronal
receptors is much more complex (126,133,134).
Mechanisms of cholinergic synaptogenesis
in the nervous system are largely elusive com-
Clustering of Nicotinic AChRs 93
Molecular Neurobiology Volume 25, 2002
pared to the NMJ and have been mainly inves-
tigated in the PNS. Studies about the CNS
synapses have been limited, mainly due to the
relatively low expression level of nicotinic
receptors in limited areas of the CNS. Thus,
compared to other receptor systems, very little
information is available about how interneu-
ronal cholinergic synapses in the CNS are built
up and maintained. In the following parts,
studies that have been made so far for charac-
terizing nicotinic synapses in the PNS and
CNS are summarized, and we attempt to pos-
tulate postsynaptic components of these
synapses, mainly based on the information
about the molecules identified at the NMJ.
Cholinergic Synapses in the
Peripheral Nervous System
Functional cholinergic synapses have been
identified in a number of peripheral neurons
from various species, e.g., superior cervical,
ciliary, and sympathetic ganglia (135–137). In
the PNS, nicotinic receptors mediate excitatory
synaptic transmission as major neurotransmit-
ter receptors, although a presynaptic function,
regulating the release of neurotransmitters, has
also been demonstrated (134,138).
Postsynaptic structures and functional
aspects of interneuronal cholinergic synapses
are best-characterized in chick ciliary ganglia
where developmental and innervation profiles
have been well-investigated. Chick ciliary gan-
glion neurons express α3, α5, β2, β4, and α7 sub-
units and, thus far, two major subtypes of
receptors differing in their subunit-composi-
tions and also functional properties have been
identified, that is, the α-BTX sensitive compo-
nent comprised of α7 subunits and MAb35-
immunoreactive receptors of which at least two
classes exist depending on the presence of β2
subunits, e.g., α3α5β2β4 and α3α5β4 (139–141). In
the chick ciliary ganglion, α7 and mAb35-
AChRs show interesting differences in their
localizations with respect to synaptic sites.
Whereas clusters of α3/α5 subunit-containing
ganglionic receptors are found at extrasynaptic
sites in addition to postsynaptic densities, those
of α7-containing receptors that represent the
most abundant population of ganglionic recep-
tors, are exclusively localized on perisynaptic
somatic spines (135,142). By ultrastructural
analysis, synaptic MAb35-AChRs were local-
ized to the postsynaptic density (PSD) opposing
presynaptic vesicle release sites. Perisynaptic α7
receptors on spines, interestingly, are present in
close proximity to the potential release sites
overlaid with vesicles (142,143). Although α7
subunits are excluded from the synapse, they
carry majority of the synaptic current and it
appears that they are important for rapid and
reliable synaptic firing (144,145).
What mechanisms could be involved in
anchoring/targeting of these receptors at their
respective sites? Recent studies show that in
chick ciliary ganglia actin filaments are colocal-
ized with α7 receptors and are active compo-
nents for maintaining α7 receptor-clusters in
the postsynaptic membrane, since depolymer-
ization of actin filaments disperses these clus-
ters and also accelerates agonist-challenged
rundown of the α7 channel function (142,146).
In addition to association, either directly or
indirectly, with f-actin, anchoring perisynaptic
α7 receptors on somatic spines appears to
involve other mechanisms, since these recep-
tors are resistant to extraction by nonionic
detergents even after treatment with actin-
depolymerizing agents (142). A recent study
has demonstrated that α7 receptor clusters are
tightly linked to membrane lipid rafts. As
shown by treatments that disperse rafts, the
integrity of these rafts is required to maintain
α7 clusters, independently of f-actin, thus offer-
ing an explanation for an additional anchoring
mechanism (147). Lipid rafts are rich in Src-
family kinases and other signaling molecules
(148). This suggests that Src and Fyn might
play a role in maintaining α7 clusters and this
could be an interesting parallel to the NMJ
where these kinases are necessary to maintain
AChR clusters (54). In contrast, ganglionic
MAb35-reactive receptors, although partly
found on somatic spines along with α7, appear
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to require different mechanisms for localiza-
tion in the plasma membrane since their func-
tional integrity is not affected by repeated
applications of nicotine and they are also read-
ily solubilized by nonionic detergents
(142,146). These receptors are targeted to the
postsynaptic density by a signal in the cyto-
plasmic portion of the α3 subunit: studies
using chimeric receptor constructs showed
that the cytoplasmic loop of the α3 subunit
mediates postsynaptic localization, whereas
the corresponding region of α5 lacks such tar-
geting information (149). Another candidate
for localization of neuronal AChRs is rapsyn,
based on its importance at the NMJ. Although
rapsyn causes clustering and detergent-insolu-
bility of various nicotinic receptors upon
expression in heterologous fibroblasts, it is not
required for clustering of ganglionic AChRs in
the superior cervical ganglion neurons, as
shown in rapsyn –/– mice (see below;137). Fur-
ther, although mRNA is present, postsynaptic
rapsyn immunoreactivity was not detected in
this ganglion nor in chick ciliary ganglia, indi-
cating that rapsyn might play a different role,
if any at all, in the nervous system.
Another complexity of interneuronal cholin-
ergic synapses originates from the presence of
glycine receptor-microdomains that are associ-
ated with the postsynaptic densities of chick
ciliary neurons (143). Chick gephyrin specifi-
cally colocalizes with these glycine receptors,
but not with MAb35-reactive AChRs. Segrega-
tion of different neurotransmitter receptors
and different subtypes of receptors into
mosaics of domains, using cognate cluster-
ing/anchoring molecules, thus, may be
another mechanism for the neuron to fine-tune
synaptic transmission.
Finally, extrasynaptic clusters of nicotinic
receptors, in addition to clustering at the post-
synaptic sites, have also been observed in the
mouse superior cervical ganglion and the frog
cardiac ganglion (137,150), which raises the
possibility that nonsynaptic localization of
nicotinic receptors, yet taking part in a signifi-
cant portion of synaptic transmission, might be
a general feature of peripheral nicotinic
synapses. Although NMDA receptors in cul-
tured hippocampal cells were found clustered
extrasynaptically in early neuronal develop-
ment, molecular explanations have not been
provided. Further, clustering of ligand-gated
ion channel receptors outside of postsynaptic
sites in mature neurons has not been ubiqui-
tously found and investigated (151).
Cholinergic Synapses in the Central
Nervous System: An Overview
Autoradiographic and subunit mapping
studies using various ligands, antibodies, and
cRNA probes have generated useful informa-
tion about the distribution of nicotinic recep-
tors and cholinergic synapses in the CNS (130).
Although these studies implicated cholinergic
functions in the brain, unequivocal identifica-
tion of cholinergic synapses carrying nicotinic
receptors as the mediator of major synaptic
transmission turned out to be difficult and has
been limited to few examples (152). This has
been attributed to the presynaptic role of nico-
tinic receptors as a primary function and
examples are well-documented by numerous
studies where presynaptic functions are shared
by a variety of neurotransmitters, e.g., gluta-
mate, dopamine, GABA, noradrenaline, and
ACh itself (134). However, a collection of
recently made studies, mostly using immuno-
cytochemical and refined-electrophysiological
analysis, begun to generate accumulating evi-
dence for the postsynaptic cholinergic func-
tion, indicating that nicotinic receptors can act
as the major carrier of synaptic current. In the
following section, studies that provided direct
or indirect evidence for the role of nicotinic
receptors in mediating rapid synaptic trans-
mission are summarized and discussed.
Immunocytochemical Characterization 
of Cholinergic Synapses
α7, α4, and β2 subunits are widely expressed
species of subunits in the brain, while expres-
sion profiles of other subunits are more limited
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(153–155). Some of the areas where these sub-
units are abundantly expressed served as good
model system for investigating postsynaptic
aspects of cholinergic synapses. However, a
number of neurons express multiple subunits
simultaneously and the question of how these
are organized as synaptic responsive elements
at the synapse is elusive and remains to be
investigated.
Strong α4 immunoreactivity has been
mapped to tyrosine hydroxylase (TH)-positive
dopaminergic neurons in substantia nigra pars
compacta (SNpc) and ventral tegmental area, of
which cell bodies and dendrites are innervated
by neurons from pedunculopontine tegmental
nuclei (PPN) and the laterodorsal tegmental
nucleus (156–158). Postsynaptic nicotinic
responses that can be evoked by stimulating
inputs from PPN and also excitability of
dopaminergic neurons in SNpc by application
of nicotine indicate that nicotinic receptors
directly mediate synaptic transmission in these
neurons (159,160). Dopaminergic neurons
express multiple nicotinic subunits and studies
from different lines suggest that the α4β2 combi-
nation of receptors among others are likely can-
didates for functional nicotinic receptors
mediating fast synaptic transmission (161–164).
Light microscopic and ultrastructural analysis
revealed some features of subcellular distribu-
tion of α4 subunits. α4-immunoreactivity was
associated with cell perikarya and dendritic
shafts, but not with spines (158,160). Labeling of
some postsynaptic structures was evident as
assessed by electron microscopic analysis, but
some nonsynaptic labeling was also identified.
Further, a detailed study using postembedding
immunogold procedures demonstrated clear
labeling of α4 at the PSD, although the fre-
quency of the labeling was low (158).
So far, studies that demonstrated association
of nicotinic receptor subunits with the PSD in
the CNS have been limited to α4 subunits.
Although α4 subunits decorate the PSD at very
low frequency in dopaminergic neurons of the
substantia nigra, PSD association has been
demonstrated more convincingly in other
brain areas such as the paraventricular nucleus
of the hypothalamus and pyramidal cells in
layer 5 of the rat cortex (165,166). The common
theme arising from these studies is the distrib-
ution of α4 subunits in the cell body and proxi-
mal rather than distal parts of dendrites. It is
notable that β2 subunits, which preferentially
assemble with α4 subunits and form high-
affinity nicotine binding sites, also exclusively
label perikarya with rare synaptic labeling in
the brain as judged by electron microscopic
analysis (154).
Another example for fast synaptic nicotinic
responses is found in the chick lateral spiri-
form nucleus (SpL) that receives cholinergic
projections from the nucleus semilunaris.
Nicotinic synapses have been identified by
the double-label immunofluorescence tech-
nique using antibodies to choline acetyl-
transferase (ChAT) and MAb35 (167).
ChAT-positive immunoreactivity was associ-
ated with that of MAb35 more preferentially in
the fibers lateral to SpL than in neurons in the
nucleus, and colocalization was pronounced in
dendrites but not on the neuronal soma of
these neurons. The clusters of MAb35-
immunoreactive nicotinic receptors were not
frequently colocalized with presynaptic vesicle
markers, suggesting that most of clusters are of
nonsynaptic origins (168). However, stimula-
tion of cholinergic afferents to SpL neurons
generated nicotinic excitatory postsynaptic
potentials (EPSPs) that can evoke action poten-
tials (167). These responses were not sensitive
to antagonists for α7 receptors and might be
mediated by α5,β2 subunit-containing recep-
tors since they are expressed by more than 90%
of the neurons in the SpL (168). Thus, nicotinic
receptors in SpL neurons are primarily concen-
trated at extrasynaptic sites, and yet they par-
ticipate in eliciting the postsynaptic response.
α7 subunits that constitute α-BTX binding
sites are enriched in the hippocampus and
some nuclei of the brain stem (155,161). Mor-
phological analysis suggests postsynaptic roles
of these receptors since there was no significant
axon terminal staining. The subcellular staining
pattern of α7 varied across different neuronal
groups in terms of the extent of dendritic label-
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ing, since all dendritic trees were labeled in
some cases and, in others, only very proximal
portion of dendrites were labeled. Even with
frequent labeling across the brain, functional α7
receptors mediating fast synaptic transmission
have been conclusively identified only in
interneurons of the hippocampus (see below).
In contrast with the PNS, clustered postsynap-
tic patch type of immunostaining was not
observed at least in tissue sections. However, in
a separate in vitro study using cultured neu-
rons from the hippocampus, clusters of α7 sub-
units were observed along the soma and
dendrites and they were colocalized with
presynaptic markers (169,170). Since most of
these cultured neurons are pyramidal cells, this
has been interpreted as segregation of α7 sub-
units into presynaptic terminals of these neu-
rons, regulating the release of glutamate. A
physiological parallel is provided by the study
where α7 receptors enchanced the release of
glutamate at the mossy fiber-CA3 pyramidal
cell synapses (171). In comparison to α7, β2 sub-
units were localized in the cell body in a diffuse
way in cultured hippocampal cells, suggesting
specific segregation of different subtypes of
receptors into different subcellular compart-
ments. The discrepancy between studies using
cultured cells and tissue sections for aggrega-
tion of α7 immunoreactivity could be due to the
system used, that is, in vivo vs in vitro, and
awaits further detailed characterization.
Functional Evidence for Cholinergic
Transmission
Direct isolation of postsynaptic responses
mediated by nicotinic receptors was made pos-
sible by recent studies that employed detailed
electrophysiological analysis. Thereby, func-
tional cholinergic synapses were demonstrated
in various principal cells and interneurons of
different brain regions. Spontaneous or nico-
tinic agonist-mediated postsynaptic responses
were observed in a number of brain areas, e.g.,
neurons in the interpeduncular nucleus and
medial habenula (172,173), nucleus ambiguus
of the brain stem (174), medial vestibular
nucleus (175), and low-threshold spike cells in
layer 5 of the rat visual cortex (176).
Fast cholinergic synaptic transmission with
interesting physiological implications was
found in the developing ferret visual cortex
(177), apart from peripheral synapses of retinal
ganglion cells (178). Some principal cells and
interneurons in the developing ferret visual
cortex displayed spontaneous EPSCs and also
stimulation of thalamic afferents elicited
cholinergic postsynaptic responses. Synaptic
currents were insensitive to α-BTX, excluding
the α7 class of receptors. Interestingly, an
increase in this widespread nicotinic synaptic
transmission coincided with the period of eye-
opening, suggesting a role of nicotinic recep-
tors in synaptogenic events or circuit
remodeling in this period.
In addition to these studies, with the impor-
tance of the hippocampus as a structure medi-
ating learning and memory and with the aid of
its relatively well-defined circuitry, much
attention has been drawn to the synaptic func-
tions of nicotinic receptors in the hippocam-
pus, revealing detailed aspects of cholinergic
functions and also receptor subtypes mediat-
ing those. Pyramidal cells and interneurons of
the hippocampus receive cholinergic innerva-
tion from the medial septum-diagonal band
complex of the basal forebrain (179–181).
Although α7 subtype-mediated synaptic cur-
rents have been reported in pyramidal neurons
of the CA1 area in some cases, generally they
appear not to carry functional nicotinic
synapses (182–184). Interneurons in the CAl
field, however, express multiple components
of nicotinic responses that differ in kinetic
properties and pharmacological profiles. Fur-
ther, different populations of interneurons
express different functional subtypes and some
express multiple classes of receptors, revealing
complexity of the cholinergic synapses. The
main, rapidly depolarizing synaptic response
in CAl interneurons is mediated by α7 recep-
tors, whereas the rest of the slowly depolariz-
ing components are mediated by other classes
comprising α2-α5 and β2-β4, which overall can
be grouped into four pharmacologically differ-
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ent subtypes (169,184–187). In support of elec-
trophysiological observations, α-BTX binding
sites were found at the underlying synapses on
interneuronal somata where cholinergic bou-
tons appear to synapse (179,188). Excitation of
these interneurons will influence the activity of
a large number of principal cells, thereby coor-
dinating overall hippocampal output (138).
Another intriguing physiological signifi-
cance of cholinergic synapses in the hippocam-
pus is provided by the study where activation
of α7 receptors enhances the LTP induction
process in the CAl shaffer collateral/commis-
sural pathway (189).
Further approaches, combining electrophys-
iology with immunocytochemistry using high-
affinity antibodies specific for nicotinic
subunits, will help to understand better the
location and postsynaptic architecture of
cholinergic synapses in the CNS.
Postsynaptic Assembly: From the
NMJ to the Nervous System
Anchoring and clustering of neurotrans-
mitter receptors at functional sites are a critical
task for neurons to perform efficient synaptic
transmission. A number of synaptic compo-
nents including clustering molecules have
been identified for other neurotransmitter
receptors (190,191). Especially, existence of
multiple isoforms for some synaptic molecules
such as the PSD95 family of proteins further
impose complicated features of the CNS
synapses. However, to date, very little infor-
mation is available for the question of how
cholinergic synapses in the nervous system are
constructed and maintained, especially in the
CNS. One plausible hypothesis would be that
structural and signaling components, which
have been characterized at the NMJ, are also
involved in the assembly of the postsynaptic
scaffold in the nervous system. Indeed, many
molecules of the NMJ are also expressed in the
PNS and CNS, and some, such as the D/UGC,
appear to assemble into functional complexes
in a similar way as in the muscle (192,193).
However, except rapsyn, the relationship
between these proteins and nicotinic synapses
has not been systematically investigated so far.
Another possibility is that interneuronal
cholinergic synapses are associated with as yet
unidentified postsynaptic scaffolding proteins.
For example, gephyrin, which is involved in
clustering of glycine and GABAA receptors,
does not appear to be a synaptic component of
cholinergic synapses (143).
Agrin May Play a Role in Postsynaptic
Assembly at CNS Synapses
Several studies have addressed the question
of whether agrin, in analogy to its crucial role at
the NMJ, plays a similar role in the formation of
CNS synapses, however, the outcome is unclear
at present. Agrin is widely expressed in the
CNS, with prominent levels in the hippocam-
pus and olfactory bulb (194). In agrin-deficient
mice, synaptic localization and clustering of
glutamate and GABAA receptors were not
affected in the hippocampus, neither in tissue
sections nor in cultured neurons (195). Similarly,
glutamatergic and GABAergic synapses are
formed normally in cultured cortical neurons
derived from agrin –/– mice, as was tested
using immunocytochemical and functional
analysis (196). In contrast, in in vitro studies
using hippocampal cultured neurons, suppress-
ing the expression of agrin by treatment with
antisense oligonucleotides or agrin-antibodies
resulted in the formation of fewer synapses that
were functionally inefficient (197,198). The dis-
crepancy among these studies might be due to
compensatory synaptogenic mechanisms in
vivo operating in the agrin-deficient mice. Some
indirect lines of evidence also suggest that agrin
might be involved in the formation of the
interneuronal synapses, including postsynaptic
assembly. Agrin expression in the developing
cortex coincide with the formation of thalamo-
cortical and intracortical synapses (199). Also,
during development of the retina, agrin is redis-
tributed from an initial diffused state to a punc-
tate pattern in the inner and outer plexiform
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layers, where it is concentrated within the
synaptic clefts (200,201). Moreover, in cultured
retinal neurons, clusters of agrin colocalize at
synaptic sites with gephyrin, one of the markers
of inhibitory synapses, and purified retinal
agrin induces AChR clustering in cultured
myotubes (202). These results suggest a role of
agrin in postsynaptic assembly, including recep-
tor clustering, at synapses in the retina. How-
ever, in the CNS, studies about localization and
expression of agrin have so far not investigated
the presence of agrin at synapses in detail.
Recently, a new form of agrin in which the NtA
domain of the N-terminus is replaced by a cell
surface-associating transmembrane domain
was isolated from murine species and was
found to be expressed mainly in the brain
(88,203). This isoform was also able to cluster
AChRs in myotube cultures, suggesting that it
might play a role in clustering of nicotinic or
other receptors at the CNS interneuronal
synapses.
With respect to cholinergic synapses, agrin
is expressed in neurons of the chick ciliary
ganglion (204). Agrin is also expressed by
the innervating cholinergic neurons of the
Edinger-Westphal nucleus: this expression,
along with agrin expression in ganglionic
neurons, coincides with the periods of
synapse formation and clustering of AChRs
(205). In tissue culture, agrin from agrin-
expressing Chinese Hamster Ovary (CHO)
cells arrests the neurite outgrowth of ciliary
neurons and induces aggregation of the
synaptic vesicle protein, synaptotagmin, sug-
gesting an effect on presynaptic differentation
(206). Therefore, agrin may play roles both in
pre- and postsynaptic differentation at cholin-
ergic synapses in the ciliary ganglion, remi-
niscent of its roles at the vertebrate NMJ.
Rapsyn Is Not Required for Clustering 
of Ganglionic AChRs
Rapsyn, which is essential for the formation
of AChR clusters at the NMJ, can cluster neu-
ronal nicotinic receptors of α7, α3/β2, α3/β4, or
α4/β2 combinations and the α1, β1, γ2-GABAA
receptor complex in heterologous cells
(137,207,208). However, evidence supporting
rapsyn as a clustering molecule in neurons is
lacking. Rapsyn mRNAs, including several
shorter splice variants that are not active in
clustering of neuronal AChRs (differently from
the full-length form), are readily detected in
chick ciliary and mouse superior cervical gan-
glia, while the expression level in the brain is
very low (137,208,209). In these studies, how-
ever, rapsyn immunoreactivity was not
detected in ganglionic neurons (137,208). Most
importantly, clusters of ganglionic AChRs con-
taining α5 and β2 subunits are present in nor-
mal number, size and densities in superior
cervical ganglia of mice lacking rapsyn, show-
ing that rapsyn is not required for clustering of
ganglionic AChRs (137). The reason for the
expression of rapsyn transcripts without pro-
teins in neurons is not clear, but could imply
that, in the nervous system, rapsyn might play
a different role than clustering.
Components of the D/UGC Are Associated
with Interneuronal Synapses in the PNS
and CNS
Dystrophin, the major component of the
D/UGC in muscle, is expressed in neurons of
the PNS and CNS. Immunohistochemical and
biochemical analysis demonstrated that dys-
trophin is associated with the PSDs in mouse
superior cervical ganglia, some neurons of the
cortex and cerebellar Purkinje cells, and is
found along the soma and dendrites as clusters
in the CNS neurons (210–213). In addition to
the muscle type, a number of short forms of
dystrophin-related gene products that still
carry critical interaction domains with other
D/UGC proteins have been identified in the
nervous system, although functional roles of
those are not clear (192,212,214,215). There
exists some evidence that these different gene
products are localized at different synaptic sites
(212). Synaptic functions of dystrophin have
been implicated in some studies. Clusters of α1
and β2 subunits of GABAA receptors were colo-
calized with dystrophin immunoreactivity in
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the hippocampus and cerebellum and they
were markedly reduced in dystrophin-deficient
mdx mice, while there was no change in the
number of gephyrin clusters (213). This sug-
gests that dystrophin is involved in the synap-
tic localization of at least some subpopulations
of GABAA receptors. A possible link between
synaptic AChRs and the D/UGC is found in
the following studies. Ganglionic axotomy gen-
erated a coinciding reversible decrease of
immunoreactivity of β-dystroglycan, dys-
trophin, and α3 AChR subunits in the mouse
superior cervical ganglion, which preceded the
decrease in the number of intraganglionic
synapses (216). In addition, synaptic localiza-
tion of α3 AChR subunits, α- and β-dystrogly-
can was reduced in the superior cervical
ganglion of mdx mice (which lack full-length
dystrophin but still express short dystrophin
isoforms). These findings suggests that full-
length dystrophin is involved in the synaptic
localization of α3, by associating with these
receptors in the same synaptic complex (217).
Therefore, dystrophin appears to be associated
with synaptic GABAA and nicotinic receptors
eventhough the role as a synaptic component is
not entirely clear.
β-dystrobrevin and α-dystrobrevin-1, mem-
bers of the dystrobrevin gene family, are
mainly expressed in neurons and glia, respec-
tively (215). β-dystrobrevin is enriched at post-
synaptic densities of major neurons in the
brain and its expression pattern resembles that
of dystrophin. β-dystrobrevin can be isolated
together with syntrophin and dystrophins
from the brain, indicating the presence of a
complex similar to the muscle D/UGC
(215,218). However, the molecular architecture
of these protein complexes appears to be dif-
ferent between the muscle and the brain since,
in dystrophin-deficient mdx mice, dystro-
brevin-syntrophin complexes are still formed
in the brain, whereas their assembly is dis-
rupted in the muscle (215). The presence of 
β-dystrobrevin in the brain, but not in the mus-
cle, further illustrates the structural difference
of the muscle and brain forms of the D/UGC
(214).
Syntrophin, another D/UGC component,
also exists as multiple forms encoded by dis-
tinct genes. Two novel variants of human ori-
gin, γ1 and γ2 isoforms, have been cloned
recently and are expressed in neurons of the
brain, mainly the cortex and hippocampus,
decorating the soma and proximal dendrites
(219). Other syntrophins (α1 and β2) are also
expressed in the hippocampus and their
mRNAs colocalize with those of dystrophins
(192). All of these syntrophin isoforms can
bind to dystrophin as shown by in vitro assays
(219,220)
Dystroglycans and utrophin also are
expressed in neurons in an analogous manner
to the aforementioned D/UGC proteins, but
they appear to also decorate some microvascu-
lature structures and glia (221,222). Utrophin
tends to lable neurons differently from dys-
trophin in a nonoverlapping manner, not only
on the cellular but also subcellular levels, sug-
gesting possibly different functional roles
between them (223).
Although these studies indicate that compo-
nents of the muscle D/UGC are widely
expressed in the brain, some at synaptic sites,
and can form similar complexes, functional
roles of these proteins with respect to CNS
synapse formation have not been unequivo-
cally established. So far, sodium channels have
been isolated as a binding partner for syn-
trophin, therefore, indicating that components
of the D/UGC can be directly associated with
neuronal ion channels (224). It remains to be
determined whether direct association with
neurotransmitter receptors also underlies the
suggested role of dystrophin at central
GABAergic and peripheral cholinergic
synapses (see above).
Possible Roles of Presynaptic Input 
and the Cytoskeleton in Maintaining
Synaptic AChRs
Maintenance of the high synaptic density of
AChRs at the NMJ requires activation of these
receptors (125). Some studies suggest that this
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might also be the case for cholinergic synapses
in the PNS. In frog cardiac ganglion neurons,
large/dense clusters of AChRs at synaptic sites
were dispersed into small clusters over the cell
surface by denervation (135). However, synap-
tic activity-dependent activation of receptors
does not appear to be necessary for the devel-
opment of some classes of receptor clusters, as
has been mainly investigated by in vitro assays
using cultured neurons. Although glutamater-
gic and glycinergic inputs are necessary for
clustering of AMPA and glycine receptors,
respectively, clustering of NMDA and GABAA
receptors does not require cognate presynaptic
input (225–228). Therefore it appears that orga-
nization of different classes of synapses
requires not only different synaptic modules,
but also different modes of activity-based reg-
ulation. A close correlate to the NMJ is found
in another aspect of the PNS, that is, in chick
ciliary ganglion neurons, presynaptic input
induces the expression of AChR mRNAs dur-
ing synaptogenesis and also maintains their
expression (229,230).
The cytoskeleton is an important component
for anchoring neuronal receptors at synaptic
sites, and the regulation of cytoskeletal assem-
bly serves as a mechanism for stabilizing or
destabilizing synaptic receptor-complexes for a
number of neuronal receptors. So far, tubulin
and actin have been identified as cytoskeletal
elements that regulate clustering events of
GABAA and glutamate receptors (191,231,232).
Interaction of receptors with the cytoskeleton
occurs mostly through clustering molecules
such as gephyrin, GABARAP, and PSD95,
although direct interactions also occur
(191,233–235). Evidence for interaction of neu-
ronal nicotinic receptors with the cytoskeleton
is limited to ganglionic α7 receptors (see
above). Although anchoring phenomena at
postsynaptic densities found for ganglionic
AChR subunits as well as for CNS subunits
such as α4, suggest involvement of the
cytoskeleton for synaptic localization of these
receptors, there has been no study supporting
this hypothesis.
Conclusions
Mechanisms of postsynaptic assembly that
were established at the NMJ potentially serve
as good models for understanding synaptic
development of interneuronal synapses.
Whether development of the neuronal cholin-
ergic synapses requires some of the molecules
that have been identified at the NMJ, or
whether it depends on unique build-up
machinery, is an intriguing open question. For
example, rapsyn, an essential component for
clustering of AChRs at the NMJ, is dispensable
for clustering of neuronal nicotinic receptors.
However, actin filaments are required for main-
taining clusters of both muscle and neuronal
AChRs and some D/UGC proteins are associ-
ated with peripheral cholinergic synapses.
Considering different classes of neuronal recep-
tors that are segregated in a given synapse, as
demonstrated in peripheral ganglia, it is also
tempting to question how these unique synap-
tic structures and functions are formed and
maintained.
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